Glaukos Corp. (GKOS) intrinsic value & 10-year financials

Glaukos Corp. (GKOS) has a Graham intrinsic value of $12.29 per share. At $164.84 on Oct 17, 2026, the stock trades 1241% above that value. Over the last 10 fiscal years revenue grew 18.0% a year to $507.4M, with an average return on invested capital of -16.6%.

Graham intrinsic value
$12.29
Share price (Oct 17, 2026)
$164.84
Price vs Graham value
1241% above
Market cap
$9.4B
Revenue (FY2025)
$507.4M
Revenue growth (10-yr CAGR)
18.0%
ROIC (10-yr avg)
-16.6%
Free cash flow (FY2025)
-$22.5M

GKOS 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $507.4M -$187.7M -$3.28 -$22.5M -39.3% -28.3%
FY2024 $383.5M -$146.4M -$2.77 -$67.6M -31.9% -20.9%
FY2023 $314.7M -$134.7M -$2.78 -$78.0M -40.9% -26.2%
FY2022 $282.9M -$99.2M -$2.09 -$63.3M -29.1% -15.0%
FY2021 $294.0M -$49.6M -$1.07 -$23.1M -11.2% -5.3%
FY2020 $225.0M -$120.3M -$2.70 -$29.9M -54.9% -16.8%
FY2019 $237.0M $15.4M $0.37 -$5.1M -21.2% -3.7%
FY2018 $181.3M -$13.0M -$0.37 $8.5M -7.2% —
FY2017 $159.3M -$92.0K $0.00 $19.2M -1.4% —
FY2016 $114.4M $4.5M $0.12 $6.0M 3.7% —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

GLAUKOS Corp is a consistent compounder, expanding top-line revenue at 18.0% annually over the past decade.

GLAUKOS Corp has historically struggled to out-earn its cost of capital, averaging just -16.6% ROIC.

GLAUKOS Corp has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, GLAUKOS Corp is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $12.29 per share.

GKOS stock: frequently asked questions

What is the intrinsic value of Glaukos Corp. (GKOS) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, GKOS's intrinsic value is about $12.29 per share.

Is GKOS stock undervalued?

At $164.84 (close on Oct 17, 2026), GKOS trades 1241% above its Graham value of $12.29. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has Glaukos Corp. grown?

Revenue went from $114.4M in fiscal 2016 to $507.4M in fiscal 2025, a compound annual growth rate of 18.0%. Net income was -$187.7M in fiscal 2025.

Does Glaukos Corp. generate free cash flow?

Glaukos Corp. generated -$22.5M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 3 of the last 10 reported years.

What is GKOS's return on invested capital?

Average ROIC over the last 10 fiscal years was -16.6%, and average return on equity was -12.2%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this GKOS data come from?

From Glaukos Corp.'s annual 10-K filings on SEC EDGAR, most recently filed Jul 29, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar surgical & medical instruments & apparatus stocks